Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Epoetin Treatment”

337 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 337 results

Testing effectiveness (Phase 2)Ended earlyNCT00372489
What this trial is testing

Extension Study to Evaluate Safety and Tolerability of Peginesatide for Long-Term Treatment of Anemia in Participants With CKD

Who this might be right for
Chronic Renal FailureChronic Kidney DiseaseAnemia
Affymax 81
Not applicableStudy completedNCT03231085
What this trial is testing

Comparison of the Rate of Preoperative Haemoglobin After Administration of Epoetin Alpha Associated With an Oral Medical Supplementation Versus Intravenous Before Surgery of Craniosynostosis at the Child

Who this might be right for
Craniosynostosis
University Hospital, Montpellier 100
Not applicableStudy completedNCT01666301
What this trial is testing

ESAs, Reticulocyte Dynamic and Hemoglobin Variability

Who this might be right for
Erythropoiesis Stimulating Agent Pharmacodynamics
Ospedale Regionale di Locarno 31
Large-scale testing (Phase 3)Study completedNCT00737477
What this trial is testing

Monthly Subcutaneous (SC) Mircera for Maintenance Treatment of Participants With Chronic Kidney Disease on Peritoneal Dialysis

Who this might be right for
Anemia
Hoffmann-La Roche 96
Large-scale testing (Phase 3)Study completedNCT00223977
What this trial is testing

2 Doses of Ferrlecit Versus Oral Iron to Treat Iron-deficiency Anemia in Peritoneal Dialysis Patients.

Who this might be right for
Iron Deficiency Anemia
Watson Pharmaceuticals 146
Testing effectiveness (Phase 2)Study completedNCT00212875
What this trial is testing

Four Dosing Regimens of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease. Protocol Addendum: Extension Study of Maintenance Therapy of PROCRIT (Epoetin Alfa) in Patients With Chronic Kidney Disease.

Who this might be right for
Chronic Kidney DiseaseAnemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 267
Testing effectiveness (Phase 2)Study completedNCT01194154
What this trial is testing

Methoxy Polyethylene Glycol-epoetin Beta (Mircera) in Participants With Chronic Kidney Disease (PRIMAVERA)

Who this might be right for
Kidney Disease, Chronic
Hoffmann-La Roche 241
Large-scale testing (Phase 3)Study completedNCT00270127
What this trial is testing

Epoetin Alfa for Anemia in Patients With Cancer Receiving Non-platinum Chemotherapy

Who this might be right for
AnemiaCancerNeoplasm
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 375
Large-scale testing (Phase 3)Study completedNCT00666835
What this trial is testing

Study to Evaluate the Efficacy and Safety of HX575 Hexal AG vs ERYPO® for the Treatment of Anemia in Hemodialysis Patients

Who this might be right for
Anemia
Sandoz 478
Testing effectiveness (Phase 2)Study completedNCT01244763
What this trial is testing

Study of Roxadustat in Non-Dialysis Chronic Kidney Disease Participants With Anemia

Who this might be right for
Chronic Kidney DiseaseAnemia
Kyntra Bio 145
Large-scale testing (Phase 3)Study completedNCT00527137
What this trial is testing

NESP Pediatric Study

Who this might be right for
Pre-dialysisEnd Stage Renal Disease
Amgen 120
Large-scale testing (Phase 3)Study completedNCT00605293
What this trial is testing

Intravenous Mircera (C.E.R.A or Methoxy Polyethylene Glycol-epoetin Beta) for the Maintenance Treatment of Hemodialysis Participants With Chronic Renal Anemia

Who this might be right for
Anemia
Hoffmann-La Roche 101
Not applicableEnded earlyNCT00875004
What this trial is testing

Epoetin Beta in Patients Undergoing Chemotherapy for Solid Tumors

Who this might be right for
AnemiaUnspecified Adult Solid Tumor, Protocol Specific
Institut du Cancer de Montpellier - Val d'Aurelle 27
Testing effectiveness (Phase 2)Study completedNCT01016366
What this trial is testing

Safety Study of Carbamylated Erythropoietin to Treat Patients With the Neurodegenerative Disorder Friedreich's Ataxia

Who this might be right for
Friedreich's Ataxia
H. Lundbeck A/S 36
Testing effectiveness (Phase 2)Study completedNCT00255749
What this trial is testing

Epoetin Alfa in Treating Patients With Anemia Who Are Undergoing Chemotherapy for Cancer

Who this might be right for
AnemiaLeukemiaLymphoma+4 more
Jonsson Comprehensive Cancer Center 89
Large-scale testing (Phase 3)Study completedNCT00028938
What this trial is testing

Chemotherapy and Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Stage IIIA or Stage IIIB Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Wake Forest University Health Sciences 1
Testing effectiveness (Phase 2)Study completedNCT00270270
What this trial is testing

Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) Therapy

Who this might be right for
Acquired Immunodeficiency SyndromeAnemia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 63
Large-scale testing (Phase 3)Not Yet RecruitingNCT07636486
What this trial is testing

Luspatercept vs Epoetin in Treating Poor Erythroid Engraftment for Hematological Malignancies

Who this might be right for
LuspaterceptEpoetinPoor Erythroid Engraftment+1 more
Nanfang Hospital, Southern Medical University 90
Large-scale testing (Phase 3)Study completedNCT00003600
What this trial is testing

Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy

Who this might be right for
AnemiaBreast CancerChronic Myeloproliferative Disorders+8 more
Alliance for Clinical Trials in Oncology 344
Testing effectiveness (Phase 2)Study completedNCT00434330
What this trial is testing

Peginesatide for Maintenance Treatment of Anemia in Participants on Hemodialysis

Who this might be right for
AnemiaChronic Kidney DiseaseChronic Renal Failure
Affymax 91
Load More Results